Dr. Alexis Thompson is a leading pediatric hematologist at the Children's Hospital of Philadelphia, specializing in the treatment of blood disorders in children. With a commitment to advancing research and patient care, she actively contributes to clinical trials aimed at improving outcomes for young patients with hematological conditions. She holds the Elias Schwartz, MD, Endowed Chair in Hematology.

Anna Lembke, MD, is a professor of psychiatry at Stanford University School of Medicine and chief of the Stanford Addiction Medicine Dual Diagnosis Clinic. She is an expert in addiction medicine, focusing on the treatment of substance use disorders and compulsive behaviors. Dr. Lembke is an author and sought-after speaker, known for her work on the changing landscape of addiction in modern society. Her bestselling book, Dopamine Nation, explores the science of pleasure and pain and offers insights into finding balance in a world of instant gratification.

Arthur Kleinman, MD, PhD, is a pioneering psychiatrist and medical anthropologist whose work has reshaped how medicine understands illness, caregiving, and the lived experience of patients. A professor at Harvard University, he is widely recognized for bridging clinical practice with the social sciences through landmark books such as The Illness Narratives. Kleinman is also a leading voice on the moral dimensions of care, emphasizing the profound human difference between curing disease and caring for those who are ill.

Jennifer Doudna, PhD, is a Nobel Prize–winning biochemist whose work revolutionized biology and medicine. A co-inventor of CRISPR-Cas9 gene-editing technology, she received the 2020 Nobel Prize in Chemistry for enabling a precise, programmable way to edit DNA. Doudna is a professor at the University of California, Berkeley, and a leading voice on the ethical and societal implications of genome editing.

Kirsten Bibbins-Domingo, PhD, MD, MAS is the 17th Editor in Chief of the Journal of the American Medical Association (JAMA) and the JAMA Network, and the Lee Goldman, MD Endowed Professor of Medicine and Professor of Epidemiology and Biostatistics at the University of California, San Francisco. She is a general internist and cardiovascular disease epidemiologist known for her leadership in prevention, health equity, and research aimed at reducing disparities. Previously she served as UCSF’s vice dean for Population Health and Health Equity and chaired the Department of Epidemiology and Biostatistics. 

Mark Skylar-Scott is an Assistant Professor of Bioengineering at Stanford University, where he’s tackling one of science’s biggest challenges—how to bioprint living tissues and organs at a scale that could transform medicine. With a background spanning Cambridge, MIT, and Harvard, Mark merges cutting-edge engineering with biology to pioneer breakthroughs in regenerative therapies, aiming to make life-saving organ replacements a reality. 

Dr. Miriam Mutebi is a breast surgical oncologist and health systems researcher based at the Aga Khan University in Nairobi, Kenya. With a focus on transforming cancer care for women in Africa, she is dedicated to understanding and addressing barriers to diagnosis and treatment. A co-founder of the Pan African Women's Association of Surgeons, Dr. Mutebi advocates for gender equity in global oncology, aiming to empower female surgeons and enhance healthcare opportunities across the continent. Her work emphasizes the importance of patient-centered care and strives to improve outcomes for patients facing breast cancer.

Dr. Sumbal Desai is Apple’s Vice President of Health and a recognized leader in digital health. Her work spans consumer health technology — from wearables and sensing innovations to large-scale health studies — and she champions technology that empowers both patients and clinicians without replacing the essential human elements of care. Her team focuses on making health data actionable and meaningful for everyday users and their physicians.

Mark Cuban is a billionaire entrepreneur, investor, and owner of the NBA's Dallas Mavericks, recognized for his role as a "shark" on "Shark Tank" and as a healthcare innovator through his company, Cost Plus Drugs, which aims to make medications more affordable and accessible. 

Ophthalmologist, cancer survivor, and the most influential medical satirist of our time.